JUPITER Not Enough To Expand CRP Testing Indication, Experts Say

Experts are not ready to call for an expansion of high-sensitivity C-reactive protein (hsCRP) testing, even though new trial results show elevated CRP testing can identify patients with low cholesterol who might benefit from statin drugs